SCHEMBL22189176

SCHEMBL22189176

CC(C(=O)c1ccccc1)S(=O)(=O)C(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.43
ADRA2A P08913 1/20 0.43
ADRA2B P18089 1/20 0.43
HTR2A P28223 1/20 0.43
HRH1 P35367 1/20 0.43
KCNH2 Q12809 1/20 0.43
TDP1 Q9NUW8 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CA12 O43570 3/20 0.41
CA1 P00915 3/20 0.41
CA2 P00918 3/20 0.41
CA9 Q16790 3/20 0.41
LMNA P02545 4/20 0.41
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
KMT2A Q03164 1/20 0.39
ATM Q13315 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
NPSR1 Q6W5P4 3/20 0.39
MAPT P10636 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20867947 0.85 CES1 (0.44) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL7754750 0.80 PGR (0.48) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL20867846 0.79 PGR (0.47) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL29012544 0.79 PGR (0.47) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL9772356 0.76 CA12 (0.49) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL10424358 0.76 TSSK1B (0.46) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL5907933 0.74 PGR (0.47) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL29012564 0.74 ITGAV (0.44) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL9405228 0.73 PGR (0.42) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL15658023 0.72 PGR (0.48) PGRADRA2AADRA2BHTR2AHRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200216430-A1 CATALYST-FREE AND REDOX-NEUTRAL INNATE TRIFLUOROMETHYLATION AND ALKYLATION OF (HETERO)AROMATICS ENABLED BY LIGHT THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2020-07-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200216430-A1 CATALYST-FREE AND REDOX-NEUTRAL INNATE TRIFLUOROMETHYLATION AND ALKYLATION OF (HETERO)AROMATICS ENABLED BY LIGHT CYBB, NOX4, NOX3 PGR 3071/4885ADRA2A 3106/4885ADRA2B 3738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.